The study analyzed pre-surgical factors affecting latent trajectories of 5-year weight loss in a bariatric surgery population. Researchers identified three distinct trajectories of weight loss for gastric sleeve and bypass operations, influenced by factors such as BMI, environmental factors, comorbidity burden, race, and weight control strategies. Monitoring real-time patient-reported outcomes post-surgery is crucial for tailoring […]

IFSO Worldwide Survey 2020-2021 shows a decrease in the number of metabolic and bariatric surgeries in 2020, but a positive trend in 2021, with sleeve gastrectomy remaining the most performed procedure. Regional protocols for surgery during COVID-19 were reported by 52% of national societies, with limited change in telemedicine and mortality data collection between 2020 […]

Researchers reviewed 15 studies on economic evaluations of bariatric surgeries and pharmacotherapy for obesity treatment in adults. They found that bariatric surgery was seen as a cost-effective approach, but there was varying opinion on the cost-effectiveness of pharmacological interventions. Most evaluations were done from healthcare system perspectives, and the researchers suggest future studies should consider […]

Efficacy and safety outcomes of bariatric surgery were similar between people living with HIV (PLWH) and controls, except for the lack of improvement in dyslipidemia in PLWH. At 1-year post-surgery, 89% of PLWH achieved ≥20% total weight loss, compared to 94% of controls. Improvement rates in hypertension and type 2 diabetes mellitus were lower in […]

Researchers conducted a study on 63 morbidly obese patients undergoing laparoscopic sleeve gastrectomy to determine the optimal percentage of excised stomach for significant weight loss and improvement in fatty liver. They found that a %rgv value of >75.3% led to more significant weight loss, while a %rgv value of >56.4% resulted in improved fatty liver […]

Patients after metabolic/bariatric surgery who sought to re-establish care mostly presented due to recurrent weight gain. Sleeve gastrectomy patients had a higher rate of revision surgery, while Roux-en-Y gastric bypass patients underwent more endoscopic interventions. Additionally, response to anti-obesity medications, particularly GLP-1 drugs, was more effective in Roux-en-Y gastric bypass patients compared to sleeve gastrectomy […]

After a 7-year follow-up, OAGB demonstrated significantly higher %EWL and %TWL compared to LSG. Quality of life scores improved in both groups, with more OAGB patients reaching very good or excellent outcomes on the BAROS score. Both procedures led to significant drops in total body weight and BMI, with most patients experiencing remission or improvement […]

Patients with inflammatory bowel disease (IBD) who underwent sleeve gastrectomy (SG) had a 48% higher risk of post-operative complications compared to those without IBD. While there was no significant difference in readmission rates or hospital costs, lengths of stay were similar between the two groups. Despite the increased complication rates, SG remains a safe weight […]

After 7 to 12 years of follow-up, individuals who underwent bariatric surgery instead of medical/lifestyle intervention showed superior glycemic control, requiring fewer diabetes medications, and experiencing higher rates of diabetes remission. An average HbA1c decrease of 1.4% at 7 years and 1.1% at 12 years was observed in the bariatric surgery group compared to the […]

The combined use of transient elastography (te) and visual liver score (vls) in assessing non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery showed high sensitivity and diagnostic accuracy. Transient elastography with a visual liver score is comparable to liver biopsy, with an overall sensitivity of 100% and […]